Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inamed Awaits North American Silicone Implant Panel Dates, Lap-Band NCD

This article was originally published in The Gray Sheet

Executive Summary

Inamed's silicone breast implant review by a Canadian regulatory panel in March could foreshadow the results of an FDA General & Plastic Surgery Devices Panel assessment in April

You may also be interested in...



Execs Should Monitor Advocacy Group Concerns, Media Coverage – Diermeier

Medical device executives should stay abreast of advocacy group concerns and media portrayal in order to effectively manage the image of their products, according to Daniel Diermeier, PhD, Northwestern University

Execs Should Monitor Advocacy Group Concerns, Media Coverage – Diermeier

Medical device executives should stay abreast of advocacy group concerns and media portrayal in order to effectively manage the image of their products, according to Daniel Diermeier, PhD, Northwestern University

Gastric Banding Less Potent Than Bypass But Clinically Beneficial – MCAC

Laparoscopic adjustable gastric banding produces a clinically important net health benefit for morbidly obese patients with co-morbidities, CMS' Medicare Coverage Advisory Committee agreed Nov. 4 in Baltimore, Md

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021454

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel